Proffered Paper: Targeting PA2G4, a novel MYCN co-factor, for the treatment of neuroblastoma. (July 2016) - Koach, J.; Murray, J.E.; McCarroll, J.; Milazzo, G.; Perini, G.; Haber, M.; Norris, M.D.; Fletcher, J.I.; Cheung, B.B.; Marshall, G.M.